RIL
AVIR icon

Rothschild Investment LLC’s Atea Pharmaceuticals AVIR Stock Holding History

Rothschild Investment LLC’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660 Buy
142
+57
+67% +$284 ﹤0.01% 3200
2026
Q1 		$457 Hold
85
– – ﹤0.01% 3154
2025
Q4 		$303 Hold
85
– – ﹤0.01% 3043
2025
Q3 		$247 Hold
85
– – ﹤0.01% 2980
2025
Q2 		$306 Buy
+85
New +$253 ﹤0.01% 2854
2024
Q3 		– Sell
-3,150
Closed -$10.4K – 2896
2024
Q2 		$10.4K Hold
3,150
– – ﹤0.01% 1096
2024
Q1 		$12.7K Hold
3,150
– – ﹤0.01% 1019
2023
Q4 		$9.61K Buy
+3,150
New +$9.54K ﹤0.01% 1001

Other funds holding AVIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AI
Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Rothschild Investment LLC's AVIR Position: Q2 2026 in Review

Rothschild Investment LLC increased its Atea Pharmaceuticals (AVIR) stake by 67% in Q2 2026, buying an estimated $284 and bringing the position to 142 shares worth $660. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

Rothschild Investment LLC first reported a position in AVIR in Q4 2023 and has held it in 8 quarters since. The position peaked at $12.7K in Q1 2024. 40 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Rothschild Investment LLC held 142 shares of Atea Pharmaceuticals worth $660 as of Q2 2026.
  • Rothschild Investment LLC bought 57 Atea Pharmaceuticals shares in Q2 2026, an estimated $284.
  • Atea Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3200 holding.
  • Rothschild Investment LLC first reported a position in Atea Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • Rothschild Investment LLC's Atea Pharmaceuticals position peaked at $12.7K in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.